CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Supernus finalizes $350M asset acquisition of Navitor’s SPN-820

SPN-820Positive
AI Analysis

Summary

Supernus Pharmaceuticals has completed a $350 million acquisition of Navitor's asset SPN-820, expanding its drug portfolio through a significant M&A transaction.

Importance:7/10
Sentiment:
0.50
M&Aasset acquisitionpipeline expansion
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on April 8, 2026 5:20 AM

Read Original